MRM Health Announces First Patient Dosed with Next Generation Live Microbiome Consortia Therapeutic MH002 in Phase 1b/2a Study in Patients with Ulcerative Colitis

3 years ago

GHENT, Belgium, Dec. 08, 2021 (GLOBE NEWSWIRE) -- MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics,…

Noema Pharma Hosting Key Opinion Leader Webinar on Stuttering

3 years ago

Friday, December 17th @ 11am ET / 5pm CETBASEL, Switzerland, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Noema Pharma, a Swiss-based…

Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 10 million sales milestone payment to Basilea

3 years ago

Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, December 08, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage…

Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock

3 years ago

MENLO PARK, Calif. and BOSTON, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company…

Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001

3 years ago

Saint-Herblain (France), December 8, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the…

Bone Therapeutics announces closing of private placement

3 years ago

REGULATED INFORMATION NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE…

Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial following first patient implantation in the UK

3 years ago

Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial following first patient implantation in the UK Successful…

Cingulate Inc. Announces Pricing of $25.0 Million Initial Public Offering

3 years ago

KANSAS CITY, Kan., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Cingulate Inc. (“Cingulate” or the “Company”), a clinical-stage biopharmaceutical company utilizing…

Telix and NUCLIBER Sign Distribution Agreement for Prostate Cancer Imaging in Spain

3 years ago

MELBOURNE, Australia and MADRID, Spain, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today…

Ascendis Pharma A/S to Host Virtual R&D Program Update on December 14

3 years ago

COPENHAGEN, Denmark, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company will host…